Anticoagulation therapy in COVID-19 patients with chronic kidney disease

Coagulopathy and derangements in the coagulation parameters are significant features of COVID-19 infection, which increases the risk of disseminated intravascular coagulation, thrombosis, and hemorrhage in these patients, resulting in increased morbidity and mortality. In times of COVID-19, special...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafiee, Mohammad Ali, Hosseini, Sayyideh Forough, Mortazavi, Mojgan, Emami, Anahita, Mojtahed Zadeh, Mahtab, Moradi, Sanaz, Shaker, Pouyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506255/
https://www.ncbi.nlm.nih.gov/pubmed/34729071
http://dx.doi.org/10.4103/jrms.JRMS_875_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506255/
https://www.ncbi.nlm.nih.gov/pubmed/34729071
http://dx.doi.org/10.4103/jrms.JRMS_875_20

Ejemplares similares